Santhera Partners Up With Ikris Pharma Network For Distribution Of Agamree In India
Aug 29 (Reuters) - SANTHERA PHARMACEUTICALS HOLDING AG SANN.S:
ENTERS INTO AGREEMENT WITH IKRIS PHARMA NETWORK FOR THE DISTRIBUTION OF AGAMREE® (VAMOROLONE) IN INDIA
AGREEMENT BETWEEN SANTHERA AND IKRIS HAS A 5-YEAR TERM AND SANTHERA WILL RECEIVE A PERCENTAGE OF NET SALES
SALES ARE EXPECTED TO BEGIN IN Q4 2025 ON A NAMED PATIENT BASIS
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Recommended Articles
Featured Tools
Top News
Meme Stocks Reappear. Avis Shares Reach New Highs Amid Short Squeeze. Can Retail Investors Still Buy?

Tesla Q1 2026 Earnings Preview: 50,000-Unit Inventory Overhang, Energy Storage Halved, 5 Core Metrics Long-Term Investors Should Really Watch

Asia-Pacific Stocks Rise Across the Board Monday as Easing Middle East Tensions Boost Market Sentiment

Intel Stock Has Surged 74% in 2026 and Earnings Land April 23 — Is INTC Still a Buy at $68?

Bitmine 2030 Stock Price Prediction: Why Did BMNR Stock Price Fall? How High Will It Rise in the Future?

Tradingkey






